Formulations

Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More


  • No Image
    Advik Laboratories Ltd

    Established in the year 1997, Advik Laboratories, a WHO and GMP certified company has been set up to manufacture pharmaceutical medicines that includes anti allergic capsules, a

  • No Image
    Ahlcon Parenterals India Ltd

    Ahlcon Parenterals India Ltd was established in year 1992 with a motto to provide BFS technology - Large Volume Parenterals / Small Volume Parenterals for the consumers at affo

  • No Image
    Aimil Pharmaceuticals India Ltd

    AIMIL has been extensively engaged in manufacturing and sale of Generic & Proprietary categories of Quality Natural Products of herbo-mineral origin. From a very modest beginnin